US2920080A
(en)
|
|
1960-01-05 |
|
Process of preparing tryptamine |
US3042685A
(en)
|
|
1962-07-03 |
|
Process of making g-fluoro tryptamine |
BE638366A
(de)
*
|
1963-10-09 |
|
|
|
FR1540484A
(fr)
|
1967-08-17 |
1968-09-27 |
Pasteur Institut |
Préparation de dérivés oxygénés de l'indole
|
US3976639A
(en)
*
|
1970-11-04 |
1976-08-24 |
Hoffmann-La Roche Inc. |
Intermediates for indoles
|
US3790596A
(en)
|
1971-05-14 |
1974-02-05 |
V Shkilkova |
Method of producing indole and substitution products of the same
|
US3853987A
(en)
|
1971-09-01 |
1974-12-10 |
W Dreyer |
Immunological reagent and radioimmuno assay
|
US3935074A
(en)
|
1973-12-17 |
1976-01-27 |
Syva Company |
Antibody steric hindrance immunoassay with two antibodies
|
US4036945A
(en)
|
1976-05-03 |
1977-07-19 |
The Massachusetts General Hospital |
Composition and method for determining the size and location of myocardial infarcts
|
PH14917A
(en)
|
1978-10-23 |
1982-01-29 |
Abbott Lab |
Anti-bacterial peptide
|
DE2905531A1
(de)
|
1979-02-14 |
1981-01-08 |
Boehringer Mannheim Gmbh |
Diagnostisches mittel zum nachweis von leukozyten in koerperfluessigkeiten
|
US4331647A
(en)
|
1980-03-03 |
1982-05-25 |
Goldenberg Milton David |
Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers
|
DE3233679A1
(de)
|
1981-12-08 |
1984-03-08 |
Wilhelm Dr.med. 8900 Augsburg Meyer-Glauner |
Carrier-tripeptid mit antifungischer wirksamkeit
|
JPS5944313A
(ja)
|
1982-09-07 |
1984-03-12 |
Yakult Honsha Co Ltd |
抗菌性組成物
|
JPS6040061A
(ja)
|
1983-08-12 |
1985-03-02 |
ユニチカ株式会社 |
抗菌剤徐放性導尿カテ−テル
|
US4626540A
(en)
|
1983-11-08 |
1986-12-02 |
Warner-Lambert Company |
Substituted 1-amino-4-nitro-acridinones and methods of treating bacterial infections and leukemia with them
|
US6309669B1
(en)
|
1984-03-16 |
2001-10-30 |
The United States Of America As Represented By The Secretary Of The Army |
Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix
|
DE3412445C2
(de)
|
1984-03-31 |
1986-10-30 |
Wilhelm Dr. 7400 Tübingen Meyer-Glauner |
Tripeptid und dieses enthaltende antifungische Mittel
|
JP2874751B2
(ja)
|
1986-04-09 |
1999-03-24 |
ジェンザイム・コーポレーション |
希望する蛋白質をミルク中へ分泌する遺伝子移植動物
|
JPS6344895A
(ja)
|
1986-08-13 |
1988-02-25 |
Kyowa Hakko Kogyo Co Ltd |
抗アミロイドa蛋白質単クロ−ン性抗体
|
US4925673A
(en)
|
1986-08-18 |
1990-05-15 |
Clinical Technologies Associates, Inc. |
Delivery systems for pharmacological agents encapsulated with proteinoids
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
US4970233A
(en)
|
1987-08-04 |
1990-11-13 |
Mchugh John E |
Treatment of Acquired Immunodeficiency Syndrome (AIDS) HTLV-111/LAV infections and Acquired Immunodeficiency Syndroms (AIDS) Related Complex (ARC)
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
JPH02295923A
(ja)
|
1989-05-10 |
1990-12-06 |
Taiyo Kagaku Co Ltd |
腸内クロストリジウム属細菌の増殖阻害剤
|
IT1237472B
(it)
*
|
1989-10-04 |
1993-06-07 |
Polifarma Spa |
Derivati di acido 3-indolpiruvico, loro procedimento di produzione ed impiego terapeutico.
|
EP0494955B1
(de)
|
1989-10-05 |
1998-07-15 |
Optein, Inc. |
Zellfreie synthese und isolierung von genen und polypeptiden
|
US5013556A
(en)
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
US5705337A
(en)
|
1990-06-11 |
1998-01-06 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: chemi-SELEX
|
WO1991019813A1
(en)
|
1990-06-11 |
1991-12-26 |
The University Of Colorado Foundation, Inc. |
Nucleic acid ligands
|
US5567588A
(en)
|
1990-06-11 |
1996-10-22 |
University Research Corporation |
Systematic evolution of ligands by exponential enrichment: Solution SELEX
|
US5637459A
(en)
|
1990-06-11 |
1997-06-10 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: chimeric selex
|
US5683867A
(en)
|
1990-06-11 |
1997-11-04 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: blended SELEX
|
US5496938A
(en)
|
1990-06-11 |
1996-03-05 |
Nexstar Pharmaceuticals, Inc. |
Nucleic acid ligands to HIV-RT and HIV-1 rev
|
US5270163A
(en)
|
1990-06-11 |
1993-12-14 |
University Research Corporation |
Methods for identifying nucleic acid ligands
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
ES2108048T3
(es)
|
1990-08-29 |
1997-12-16 |
Genpharm Int |
Produccion y utilizacion de animales inferiores transgenicos capaces de producir anticuerpos heterologos.
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
JP2919142B2
(ja)
|
1990-12-27 |
1999-07-12 |
株式会社東芝 |
感光性組成物およびそれを用いたパターン形成方法
|
DE4101895C1
(de)
|
1991-01-23 |
1991-12-05 |
Forschungszentrum Juelich Gmbh, 5170 Juelich, De |
|
AU1879892A
(en)
|
1991-04-24 |
1992-12-21 |
Warner-Lambert Company |
Cck analogs containing alpha-substituted amino acids
|
US5556744A
(en)
|
1992-05-29 |
1996-09-17 |
The Trustees Of The University Of Pennsylvania |
Methods and compositions for diagnosing and treating certain HIV infected patients
|
BR9306984A
(pt)
|
1992-08-27 |
1999-01-12 |
Deakin Res Ltd |
Análogo de antígeno de peptídeo de um antígeno de peptídeo nativo vacina anticorpo processo para vacinar um hospedeiro necessitando deste tratamento estojo diagnóstico processos para preparar um análogo de um antiígeno de um antígeno de peptídeo nativo para preparar uma vacina para analisar uma amostra para um antígeno de peptídeo nativo e para analisar uma amostra para um anticorpo
|
CA2167167A1
(en)
|
1993-07-19 |
1995-02-02 |
Alfred Pollak |
Hydrazino-type radionuclide chelators having an n3s configuration
|
ATE250628T1
(de)
|
1993-10-14 |
2003-10-15 |
Scripps Research Inst |
Rohr bestehend aus zyklischen peptiden
|
US5807718A
(en)
|
1994-12-02 |
1998-09-15 |
The Scripps Research Institute |
Enzymatic DNA molecules
|
US6303567B1
(en)
|
1995-03-14 |
2001-10-16 |
Praecis Pharmaceuticals, Inc . |
Modulators of β-amyloid peptide aggregation comprising D-amino acids
|
AU5122196A
(en)
|
1995-03-31 |
1996-10-16 |
Takeda Chemical Industries Ltd. |
Cysteine protease inhibitor
|
JPH11508452A
(ja)
|
1995-07-11 |
1999-07-27 |
デグッサ アクチエンゲゼルシャフト |
ペプチドおよびn−カルバモイル保護されたペプチドの新規製造法
|
WO1997016191A1
(en)
|
1995-11-02 |
1997-05-09 |
Warner-Lambert Company |
Inhibition of amyloidosis by 9-acridinones
|
WO1997019208A1
(en)
|
1995-11-22 |
1997-05-29 |
Northwestern University |
Method of encapsulating a material in a carbon nanotube
|
WO1997049722A1
(fr)
|
1996-06-25 |
1997-12-31 |
Nisshin Flour Milling Co., Ltd. |
Depsipeptides et medicaments contenant ces composes comme ingredient actif
|
US6610478B1
(en)
|
1996-08-16 |
2003-08-26 |
Yale University |
Phenotypic conversion of cells mediated by external guide sequences
|
US6617114B1
(en)
|
1996-10-31 |
2003-09-09 |
Karo Bio Ab |
Identification of drug complementary combinatorial libraries
|
EP0941334B1
(de)
|
1996-11-06 |
2004-06-02 |
THE UNITED STATES OF AMERICA, as represented by the Secretary of the Department of Health and Human Services |
Protease-aktivierbare pseudomonas exotoxin-a-ähnliche proproteine
|
JPH10245342A
(ja)
|
1997-03-03 |
1998-09-14 |
Mitsui Norin Kk |
β−アミロイド蛋白の神経細胞毒性低減剤
|
US6514686B2
(en)
|
1997-04-28 |
2003-02-04 |
The University Of British Columbia |
Method and composition for modulating amyloidosis
|
US6001868A
(en)
*
|
1997-05-30 |
1999-12-14 |
The Regents Of The University Of California |
Indole-3-carbinol (I3C) derivatives and methods
|
DE19725619A1
(de)
|
1997-06-17 |
1998-12-24 |
Fraunhofer Ges Forschung |
Peptide als Agonisten und/oder Inhibitoren der Amyloidbildung und Zytotoxizität sowie der Verwendung bei Alzheimer'schen Krankheit, beim Typ II Diabetes mellitus und bei spongiformen Encephalopathien
|
DE69932414T2
(de)
|
1998-02-23 |
2007-02-22 |
South Alabama Medical Science Foundation, Mobile |
Indol-3-propionsäure, salze und ester davon als arzneimittel #
|
US6277870B1
(en)
|
1998-05-04 |
2001-08-21 |
Astra Ab |
Use
|
EP2180050B1
(de)
|
1998-05-07 |
2016-04-20 |
Universite Libre De Bruxelles |
Auf Cytotoxinen basierendes biologisches Einschlusssystem
|
JP3340699B2
(ja)
|
1998-06-05 |
2002-11-05 |
東京瓦斯株式会社 |
膵外分泌機能診断剤
|
WO2000030683A1
(fr)
*
|
1998-11-19 |
2000-06-02 |
Shionogi & C0., Ltd. |
Composes prophylactiques et/ou therapeutiques destines a des maladies du systeme nerveux central et possedant des composes antagonistes du recepteur de txa2 et/ou inhibiteurs de la txa2 synthase
|
JP2000193661A
(ja)
|
1998-12-25 |
2000-07-14 |
Tokyo Rika Kikai Kk |
痴呆症の検査方法
|
TWI243672B
(en)
|
1999-06-01 |
2005-11-21 |
Astrazeneca Ab |
New use of compounds as antibacterial agents
|
US6361861B2
(en)
|
1999-06-14 |
2002-03-26 |
Battelle Memorial Institute |
Carbon nanotubes on a substrate
|
GB9916810D0
(en)
|
1999-07-16 |
1999-09-22 |
Cancer Res Campaign Tech |
Killing cells
|
MXPA02001349A
(es)
|
1999-08-09 |
2002-07-22 |
Tripep Ab |
Inhibidores de la polimerizacion de proteinas y metodos de uso.
|
GB9922013D0
(en)
|
1999-09-17 |
1999-11-17 |
Univ Sussex |
Peptides
|
US6689753B1
(en)
|
1999-11-05 |
2004-02-10 |
Axonyx, Inc. |
β sheet breaker peptide analogs that inhibit β pleated sheet formation in amyloid β-peptide
|
ATE393221T1
(de)
|
1999-11-29 |
2008-05-15 |
Avi Biopharma Inc |
Gegen bakterielle 16s und 23s rrnas gerichtete ungeladene antisense oligonukleotide und deren verwendungen
|
WO2001045726A2
(en)
|
1999-12-21 |
2001-06-28 |
Mars, Incorporated |
The use of procyanidins in the modulation of cytokine gene expression and protein secretion
|
JP2003519192A
(ja)
|
1999-12-30 |
2003-06-17 |
プロテオテック・インコーポレーテッド |
アルツハイマー病におけるアミロイド症および他のアミロイド症の治療のためのカテキンおよび緑茶抽出物
|
US20020006954A1
(en)
|
2000-03-02 |
2002-01-17 |
Oklahoma Medical Research Foundation |
Desmethyl tocopherols for preventing or slowing degenerative neurological diseases
|
CA2411542A1
(en)
|
2000-06-09 |
2001-12-13 |
Teni Boulikas |
Encapsulation of polynucleotides and drugs into targeted liposomes
|
US20040152672A1
(en)
*
|
2000-08-09 |
2004-08-05 |
Carson Dennis A. |
Indole compounds useful for the treatment of cancer
|
DE10043282A1
(de)
|
2000-09-02 |
2002-03-28 |
Kurt Heininger |
Verwendung von Inhibitoren der Amyloid-beta-Protein-Bildung
|
US20020151506A1
(en)
|
2000-12-29 |
2002-10-17 |
Castillo Gerardo M. |
Catechins for the treatment of fibrillogenesis in Alzheimer's disease, Parkinson's disease, systemic AA amyloidosis, and other amyloid disorders
|
JP3560333B2
(ja)
|
2001-03-08 |
2004-09-02 |
独立行政法人 科学技術振興機構 |
金属ナノワイヤー及びその製造方法
|
ITVR20010031A1
(it)
|
2001-03-12 |
2002-09-12 |
Hisanori Suzuki |
Uso di epigallocatechin-3-gallato o suoi derivati nella profilassi e nel trattamento delle malattie neurodegenerative.
|
AU2002254328A1
(en)
|
2001-03-20 |
2002-10-03 |
University Of Chicago |
Inhibitors and disassemblers of fibrillogenesis
|
WO2002094857A1
(en)
|
2001-05-23 |
2002-11-28 |
The Curators Of The University Of Missouri |
Inverse solid phase synthesis of peptides
|
RU2196568C1
(ru)
*
|
2001-08-08 |
2003-01-20 |
Киселев Всеволод Иванович |
Фармацевтическая композиция для профилактики и лечения дисплазий и рака шейки матки и папилломатоза гортани, а также способ профилактики и лечения этих заболеваний на ее основе
|
CA2357053A1
(en)
|
2001-09-04 |
2003-03-04 |
Unknown |
Effectiveness of a combination of antioxidant substances for the treatment of alzheimer's disease
|
US6620850B2
(en)
*
|
2001-09-19 |
2003-09-16 |
University Of Florida |
Materials and methods for treatment of neurological disorders involving overactivation of glutamatergic ionotropic receptors
|
US6976639B2
(en)
|
2001-10-29 |
2005-12-20 |
Edc Biosystems, Inc. |
Apparatus and method for droplet steering
|
WO2003039540A2
(en)
|
2001-11-09 |
2003-05-15 |
Sepracor Inc. |
D-amino acid oxidase inhibitors for learning and memory
|
US20040052928A1
(en)
|
2002-09-06 |
2004-03-18 |
Ehud Gazit |
Peptides and methods using same for diagnosing and treating amyloid-associated diseases
|
US7781396B2
(en)
|
2002-01-31 |
2010-08-24 |
Tel Aviv University Future Technology Development L.P. |
Peptides directed for diagnosis and treatment of amyloid-associated disease
|
US20070021345A1
(en)
|
2003-06-30 |
2007-01-25 |
Ehud Gazit |
Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
|
DE10206723A1
(de)
|
2002-02-18 |
2003-09-04 |
Ulrich Schraermeyer |
Therapie von Erkrankungen des Auges und des Zentralen Nervensystems
|
US6803379B2
(en)
|
2002-06-04 |
2004-10-12 |
Jose A. Fernandez-Pol |
Pharmacological agents and methods of treatment that inactivate pathogenic prokaryotic and eukaryotic cells and viruses by attacking highly conserved domains in structural metalloprotein and metalloenzyme targets
|
AU2002950217A0
(en)
|
2002-07-16 |
2002-09-12 |
Prana Biotechnology Limited |
8- Hydroxy Quinoline Derivatives
|
US20040029830A1
(en)
|
2002-08-06 |
2004-02-12 |
Hebert Rolland F. |
Water-soluble indole-3-propionic acid
|
US7491699B2
(en)
|
2002-12-09 |
2009-02-17 |
Ramot At Tel Aviv University Ltd. |
Peptide nanostructures and methods of generating and using the same
|
WO2004060791A1
(en)
|
2003-01-07 |
2004-07-22 |
Ramot At Tel Aviv University Ltd. |
Peptide nanostructures encapsulating a foreign material and method of manufacturing same
|
WO2005016339A1
(en)
*
|
2003-07-24 |
2005-02-24 |
Case Western Reserve University |
Methods for the treatment of parkinson's disease
|
US7348399B2
(en)
|
2003-08-29 |
2008-03-25 |
Louisiana Tech University Foundation, Inc. |
Nanofabricated polypeptide multilayer films, coatings, and microcapsules
|
EP1663199B1
(de)
|
2003-09-25 |
2013-04-03 |
Tel Aviv University Future Technology Development L.P. |
Zusammensetzungen und diese verwendende verfahren zur behandlung von amyloid-bedingten erkrankungen
|
WO2005031362A2
(en)
|
2003-10-02 |
2005-04-07 |
Ramot At Tel Aviv University Ltd. |
Novel antibacterial agents and methods of identifying and utilizing same
|
CA2558721A1
(en)
*
|
2004-02-27 |
2005-09-15 |
Pfizer Inc. |
Screening method for emulators of neural activity and digestive system using gpr35
|
US7089736B2
(en)
*
|
2004-07-27 |
2006-08-15 |
General Motors Corporation |
Variable nozzle turbo (VNT) solenoid temperature estimator
|
US20060035890A1
(en)
*
|
2004-08-10 |
2006-02-16 |
Amit Banerjee |
Compounds and methods for the treatment of ubiquitin conjugating disorders
|
US7732479B2
(en)
|
2004-08-19 |
2010-06-08 |
Tel Aviv University Future Technology Development L.P. |
Compositions for treating amyloid associated diseases
|
EP1937260A2
(de)
*
|
2005-09-16 |
2008-07-02 |
University of Pittsburgh |
In-vivo- und in-vitro-verfahren zum nachweis von amyloidablagerungen mit wenigstens einem amyloidogenen protein
|